Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Dr Emanuela Costigliola

Chief Marketing Officer

Emanuela’s extensive career brings a wealth of experience in marketing in the life science and biotechnology industry and a track record of senior leadership roles at some of the leading players including, GE Healthcare, Qiagen, Life Technologies and most recently as Head of Marketing and Communications at the Cell and Gene Therapy Catapult. An advocate for sales and launch excellence, holding a PhD in Immunology and Molecular Pathology, she was the Global Capability Director in Immuno-oncology for AstraZeneca and has consulted and developed commercial capabilities for key players in the field.

 

 

Get our latest updates straight to your inbox